Kathryne sells ESRX 65.74: State Governments May Spend $55 Billion on Hepatitis C Medications
ST. LOUIS, July 17, 2014 /PRNewswire/ -- State legislatures will need to find billions in their budgets to purchase costly new hepatitis C therapy, according to a new state-by-state analysis released today by Express Scripts (NASDAQ: ESRX). More than ... ...
45 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home